94 results
Page 2 of 5
8-K
EX-1.1
qjm2q
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
424B5
am1pkn80e
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
m9oo1bzssdm2wp
13 Sep 22
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
oadivzl6nk ivnfki1l
13 Sep 22
POINT Biopharma Announces Proposed Public Offering of Common Stock
4:12pm
424B3
hz4spi7
11 Jul 22
Prospectus supplement
4:32pm
POS AM
l645f
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
wdgb380r2vo0e
1 Jul 22
Shelf registration
4:13pm
S-3
EX-1.2
r9j0anrt4vig5m2pyxvs
1 Jul 22
Shelf registration
4:13pm
424B3
EX-31.2
9u6n2s6 lmty6
13 May 22
Prospectus supplement
8:18am
424B3
hxtk4
13 May 22
Prospectus supplement
8:18am
424B3
EX-31.1
zxdi5rg92ljv4
13 May 22
Prospectus supplement
8:18am
DEF 14A
ps0crflf5 glqk2xaio
28 Apr 22
Definitive proxy
8:36am
424B3
0loaar xlyb3ce
31 Mar 22
Prospectus supplement
11:42am
POS AM
gtrx2sphmtc3
25 Mar 22
Prospectus update (post-effective amendment)
8:41am